Fig. 2.
Fig. 2. Variability in antifibrinolytic and procoagulant effect of rFVIIa in 17 plasma samples from patients with severe hemophilia A. / (A) Clys½-VIIa values were determined in plasma samples from 17 patients with severe hemophilia A following the example in Figure 1B. (B) Cclot½-VIIa values were determined in plasma samples from 17 patients with severe hemophilia A following the example in Figure 1C. The horizontal line indicates medians.

Variability in antifibrinolytic and procoagulant effect of rFVIIa in 17 plasma samples from patients with severe hemophilia A.

(A) Clys½-VIIa values were determined in plasma samples from 17 patients with severe hemophilia A following the example in Figure 1B. (B) Cclot½-VIIa values were determined in plasma samples from 17 patients with severe hemophilia A following the example in Figure 1C. The horizontal line indicates medians.

Close Modal

or Create an Account

Close Modal
Close Modal